THERAPEUTICSMD INC (TXMD)
US88338N2062 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.32M | -10.28M | 112.00M | -172.42M | -183.52M | |||
| Depreciation Amortization | 1.04M | 922.00K | 1.19M | 740.00K | 1.04M | |||
| Change In Working Capital | -2.36M | -17.45M | -4.09M | 4.59M | -3.32M | |||
| Interest Paid | N/A | 0.00 | 13.55M | 25.07M | 25.85M | |||
| Other non cash items | -2.49M | -21.34M | -113.18M | 24.40M | 26.33M | |||
| OPERATING CASH FLOW | -7.12M | -48.14M | -4.08M | -142.69M | -159.47M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -360.00K | -2.22M | -1.60M | |||
| Other Investing Activity | N/A | 0.00 | 223.83M | 0.00 | N/A | |||
| INVESTING CASH FLOW | N/A | 0.00 | 223.48M | -2.22M | -1.60M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | -219.43M | -50.00M | 50.00M | |||
| Stock Issued/Repurchased | N/A | 3.15M | -14.51M | 184.67M | 31.97M | |||
| Other Financing Activity | N/A | N/A | -1.27M | -5.12M | -1.25M | |||
| FINANCING CASH FLOW | 2.00M | 3.15M | -235.21M | 129.55M | 80.72M | |||
| CHANGE IN CASH | -5.12M | -44.99M | -15.81M | -15.36M | -80.35M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.12M | -48.14M | -4.08M | -142.69M | -159.47M | |||
| Capital Expenditure | N/A | 0.00 | -360.00K | -2.22M | -1.60M | |||
| FREE CASH FLOW | -7.12M | -48.14M | -4.44M | -144.91M | -161.07M | |||
All data in USD